Effect of Baduanjin Sequential Therapy on the Quality of Life and Cardiac Function in Patients with AMI After PCI: A Randomized Controlled Trial

Table 2

The changes of SF-36 subscales during the 24 weeks.

Measure	Control group (n = 39)	BST (n = 43)	BST vs. control group (95% CI)	value
Physical functioning
Baseline	77.05 ± 17.15	71.51 ± 17.27	−5.54 (−13.12 to 2.04)	0.150
12 weeks	80.13 ± 16.60	86.33 ± 10.73	6.20 (0.11 to 12.28)	0.051
24 weeks	82.69 ± 12.34	90.11 ± 10.72	7.42 (2.35 to 12.49)	0.005
Role physical
Baseline	35.89 ± 32.34	34.88 ± 38.76	−1.01 (−16.79 to 14.76)	0.899
12 weeks	44.23 ± 33.67	70.34 ± 32.39	26.12 (11.59 to 40.64)	0.001
24 weeks	69.87 ± 40.63	90.11 ± 16.49	20.24 (6.85 to 33.64)	0.004
Bodily pain
Baseline	61.90 ± 21.61	56.44 ± 25.09	−5.46 (−15.80 to 4.88)	0.297
12 weeks	80.97 ± 17.70	79.30 ± 13.59	−1.67 (−8.57 to 5.23)	0.631
24 weeks	80.35 ± 19.89	90.05 ± 11.81	9.69 (2.58 to 16.80)	0.008
General health
Baseline	56.92 ± 15.08	52.00 ± 14.33	−4.92 (−11.38 to 1.54)	0.134
12 weeks	65.28 ± 16.27	59.58 ± 19.81	−5.70 (−13.72 to 2.31)	0.161
24 weeks	63.54 ± 18.73	77.84 ± 16.19	14.30 (6.62 to 21.98)	<0.001
Vitality
Baseline	59.23 ± 14.31	55.58 ± 12.21	−3.65 (−9.48 to 2.18)	0.216
12 weeks	62.18 ± 14.99	67.21 ± 9.96	5.03 (−0.64 to 10.70)	0.081
24 weeks	62.31 ± 8.57	73.95 ± 8.42	11.65 (7.91 to 15.38)	<0.001
Social function
Baseline	83.97 ± 24.15	77.61 ± 26.10	−6.36 (−17.45 to 4.73)	0.257
12 weeks	71.28 ± 24.62	72.56 ± 20.94	1.28 (−8.74 to 11.29)	0.801
24 weeks	71.79 ± 24.37	82.32 ± 12.87	10.53 (1.78 to 19.28)	0.019
Role emotional
Baseline	61.53 ± 42.26	47.98 ± 38.04	−13.55 (−31.20 to 4.09)	0.130
12 weeks	69.23 ± 40.74	81.39 ± 25.51	12.16 (−3.02 to 27.34)	0.114
24 weeks	70.08 ± 38.08	96.12 ± 10.81	26.04 (13.31 to 38.77)	<0.001
Mental health
Baseline	71.28 ± 16.51	66.32 ± 17.07	−4.96 (−12.35 to 2.44)	0.186
12 weeks	78.97 ± 15.78	80.19 ± 13.38	1.21 (−5.20 to 7.62)	0.708
24 weeks	74.87 ± 15.27	82.23 ± 17.38	7.36 (0.14 to 14.58)	0.046
Health transition
Baseline	36.54 ± 26.19	44.19 ± 24.90	7.65 (−3.58 to 18.87)	0.179
12 weeks	44.87 ± 22.34	60.81 ± 24.49	15.94 (5.60 to 26.28)	0.003
24 weeks	51.28 ± 22.18	82.56 ± 19.31	31.28 (21.99 to 40.56)	<0.001

Data are presented as mean ± SD. values were calculated by t-test for continuous variables.